APA

Garnier A., Delbos F., Guillaume T., Peterlin P., Le Bourgeois A., Béné M. C., Le Bris Y., Malard S., Duquesne A., Gauvrit I., Moreau P., Cesbron A. & Chevallier P. (20190715). Rituximab for second desensitization in patients with rebound of donor-specific anti-HLA antibodies before T-replete haplo-transplant using high-dose post-transplant cyclophosphamide. : Bone marrow transplantation.

Chicago

Garnier Alice, Delbos Florent, Guillaume Thierry, Peterlin Pierre, Le Bourgeois Amandine, Béné Marie C, Le Bris Yannick, Malard Stéphanie, Duquesne Alix, Gauvrit Isabelle, Moreau Philippe, Cesbron Anne and Chevallier Patrice. 20190715. Rituximab for second desensitization in patients with rebound of donor-specific anti-HLA antibodies before T-replete haplo-transplant using high-dose post-transplant cyclophosphamide. : Bone marrow transplantation.

Harvard

Garnier A., Delbos F., Guillaume T., Peterlin P., Le Bourgeois A., Béné M. C., Le Bris Y., Malard S., Duquesne A., Gauvrit I., Moreau P., Cesbron A. and Chevallier P. (20190715). Rituximab for second desensitization in patients with rebound of donor-specific anti-HLA antibodies before T-replete haplo-transplant using high-dose post-transplant cyclophosphamide. : Bone marrow transplantation.

MLA

Garnier Alice, Delbos Florent, Guillaume Thierry, Peterlin Pierre, Le Bourgeois Amandine, Béné Marie C, Le Bris Yannick, Malard Stéphanie, Duquesne Alix, Gauvrit Isabelle, Moreau Philippe, Cesbron Anne and Chevallier Patrice. Rituximab for second desensitization in patients with rebound of donor-specific anti-HLA antibodies before T-replete haplo-transplant using high-dose post-transplant cyclophosphamide. : Bone marrow transplantation. 20190715.